Provider
Also: Abbott sells 150 million of its rapid, app-paired COVID-19 test to the White House; Platform launches for chronic disease patients juggling multiple providers.
Masimo's O3 Regional Oximeter can be integrated with its SedLine brain function monitor or its Root patient monitoring and connectivity platform.
The new analysis of a Pear Therapeutics-based randomized controlled trial came alongside another investigation that spotted early signs of treatment dropout.
Patient speaker Monica Evason discusses the benefits of making community-based patient care more personal and human.
This week's top stories include the VA giving scheduling technology a test run, a requirement that nursing homes test their staffs for COVID-19 and Amwell getting a $100 million funding boost from Google Cloud.
Roundup: UK rehab centre offers robotics equipment for patients, new electronic discharge summaries…
Also, health tech investments in Dubai and India explored.
Professor Sam Shah, founder and director of Faculty of Future Health, says the digital divide must be addressed by greater investment.
While on average participants lowered their anxiety and depression, a fraction of the original participants filled in the 9-month follow up.